Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects?

Maraone, Annalisa; Tarsitani, Lorenzo; Pinucci, Irene; Pasquini, Massimo

Maraone, Annalisa; Tarsitani, Lorenzo; Pinucci, Irene; Pasquini, Massimo.

Afiliação

Maraone A; Department of Human Neurosciences, Sapienza University of Rome, Rome 00185, Lazio, Italy.
Tarsitani L; Department of Human Neurosciences, Sapienza University of Rome, Rome 00185, Lazio, Italy.
Pinucci I; Department of Human Neurosciences, Sapienza University of Rome, Rome 00185, Lazio, Italy.
Pasquini M; Department of Human Neurosciences, Sapienza University of Rome, Rome 00185, Lazio, Italy. massimo.pasquini@uniroma1.it.

World J Psychiatry ; 11(9): 568-580, 2021 Sep 19.

Article em En | MEDLINE | ID: mdl-34631461

Palavras-chave

Antiglutamatergic agents; Duration of untreated illness; Early intervention; Glutammate; Neurophysiopathology; Obsessive-compulsive disorder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article